acarix

Press

August 6, 2024

11 Apr 2024

Acarix adopts new growth-focused business model and provides outlook update as part of our ongoing strategic review

Acarix, a leader in advanced acoustic- and algorithm-based cardiac diagnostics, announces the adoption of a new innovative usage-based ...

Continue reading

acarix

Press

August 6, 2024

08 Apr 2024

Ny hälsoekonomisk analys presenterad på ACC styrker kostnadseffektiviteten i Acarix CADScor System

Acarix, ledande aktör inom akustiskbaserad hjärtdiagnostik, tillkännager idag resultaten från en presentation på årets American College...

Continue reading

acarix

Press

August 6, 2024

08 Apr 2024

New Health Economic Analysis Presented at ACC Highlights The Acarix CADScor System’s Cost-Effectiveness

Acarix, a leader in acoustic-based Cardiac Diagnostics, is pleased to announce the results from a 2024 American College of Cardiology (...

Continue reading

acarix

Press

August 6, 2024

05 Apr 2024

Acarix has submitted application for cross-trading at OTCQB in the US

New York, New York, April 5, 2024 – Acarix, a leader in advanced acoustic-based cardiac diagnostics announces the submission of an appl...

Continue reading

acarix

Press

August 6, 2024

05 Apr 2024

Acarix lämnar in ansökan om handel av bolagets aktie på OTCQB-marknaden i USA

New York, New York, 5 april 2024 – Acarix, ledande inom akustisk- och algoritmbaserad hjärtdiagnostik, meddelar idag inlämnandet av en ...

Continue reading

acarix

Press

August 6, 2024

20 Mar 2024

Acarix announces the outcome of the exercise of warrants of series 2024:U1 (TO2)

The Board of directors of Acarix AB ("Acarix" or the "Company") today announces the outcome of the exercise period ...

Continue reading

acarix

Press

August 6, 2024

20 Mar 2024

Acarix offentliggör utfall av utnyttjande av teckningsoptioner av serie 2024:U1 (TO2)

Styrelsen för Acarix AB (”Acarix” eller ”Bolaget”) offentliggör idag utfallet av utnyttjandeperioden för teckningsoptioner av serie 202...

Continue reading

acarix

Press

August 6, 2024

19 Mar 2024

Acarix erhåller avsiktsförklaringar avseende nyttjande av teckningsoptioner av serie TO 2

Acarix AB (”Acarix” eller ”Bolaget”) har mottagit muntliga avsiktsförklaringar avseende nyttjande av Teckningsoptionerna av serie TO 2 ...

Continue reading

acarix

Press

August 6, 2024

19 Mar 2024

Acarix receives declarations of intent to exercise warrants of series TO 2

Acarix AB ("Acarix" or the "Company") has received oral declarations of intent to exercise Warrants of series TO 2 ...

Continue reading

acarix

Press

August 6, 2024

15 Mar 2024

VD köper aktier i Acarix

New York, New York, 15 mars 2024 – Acarix, ledande inom akustisk- och algoritmbaserad hjärtdiagnostik, meddelar att Aamir Mahmood, nyli...

Continue reading

acarix

Press

August 6, 2024

15 Mar 2024

CEO purchases shares in Acarix

New York, New York, March 15, 2024 – Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces that Aamir Mahmood, rec...

Continue reading

acarix

Press

August 6, 2024

06 Mar 2024

The exercise period for Acarix warrants of series 2024:U1 (TO2) begins today

The exercise period for the warrants of series 2024:U1 (TO2) (the "Warrants") issued in connection with Acarix AB ("Acar...

Continue reading